Cytokinetics Inc - Company Profile
Powered by 
All the sales intelligence you need on Cytokinetics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cytokinetics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cytokinetics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Cytokinetics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 15 May 2023 | Cytokinetics Inc Enters Phase I Clinical Trial Agreement with Celerion Inc for aficamten (GDCT0491703) | Contract Service Agreement |
Cytokinetics Inc
|
Celerion Inc
|
| 01 Mar 2023 | Cytokinetics to Raise Up to USD300 Million in Public Offering of Common Stock | Equity Offering | - |
Cytokinetics Inc |
| 06 Dec 2022 | Cytokinetics Inc Enters Phase I Clinical Trial Agreement with Labcorp Drug Development for CK-136 (GDCT0474254) | Contract Service Agreement |
Cytokinetics Inc
|
Labcorp Drug Development |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer